We would like to inform you that we have been selected and invited to Asia’s largest partnering event “BioJapan 2024” to be held at Yokohama. We have an exhibition booth.
[Period] October 9th (Wed) to 11th (Fri), 2024
[Venue] Pacifico Yokohama
[Booth] in the Japan Healthcare Venture Summit V-24
R & D of HiPep Laboratories have focused on bio-recognition and recently several fundamental technologies have been established. Those are novel bio-detection system (microarrays with a novel principles) for diagnostics and drug discovery technologies using peptide derivatives as capturing molecules.
We propose technology transfer, partnering and/or collaboration concerning established technologies as well as materials.
(1) Bio-detection in the next generation: “PepTenChip®” system, based on novel principal, a original peptide microarray with fluorescent labeled de novo designed peptide as capturing molecules. Applications in recently accomplished diagnostic results on pre-gastric cancer and discrimination in multiple sclerosis will be demonstrated using an actual detector PepTenCam with a data-base. For demonstration, please email us in advance with your preferred date and time: contact ✉PepTenChip@hipep.jp.
(2) Discovery tools with deconvolution technologies: OPOB Libraries.
(3) Novel gene-controlling drug candidate PIPA, peptides consisting of Py & Im, sequence specific binding to dsDNA.
(4) Novel longer lasting angiogenic peptide, AGP, for regenerative medicine/cell transplantation
